Secondary Breast Cancer and the Insurer's 12-Month Test

A diagnosis of secondary, or metastatic, breast cancer is one of the hardest things a person can be told, and it sits in an uncomfortable place when it comes to life insurance: clinically incurable, yet very often not what an insurer means by "terminal" for the purposes of a policy claim. Many women live with secondary breast cancer for years, sometimes many years, managing it as a long-term condition through successive lines of treatment, and that reality does not fit neatly against the twelve-month test almost every UK terminal illness benefit is built around.

This guide is written specifically for that gap: for the reader whose diagnosis is unquestionably terminal in the ordinary sense of the word, but whose current prognosis does not meet the insurer's twelve-month definition, and who needs to understand why a claim may not pay yet, and what has to be kept in place carefully until it does.

Is secondary breast cancer classed as terminal?

Clinically, secondary breast cancer, sometimes called metastatic breast cancer or stage 4 breast cancer, means the cancer has spread beyond the breast and nearby lymph nodes to other parts of the body, most commonly the bones, liver, lungs or brain. It is generally described by clinicians as treatable but not curable, and modern treatment can control the disease, sometimes for a considerable time, even though it cannot remove it entirely. In everyday language, and in the way many patients and families understand it, this is a terminal diagnosis: it means the disease will ultimately be the cause of death, even if that is not imminent.

Insurers use a narrower, specific definition that does not automatically match this. A terminal illness claim under a UK life policy almost always requires a registered medical practitioner to certify that, in reasonable medical certainty, life expectancy is twelve months or less. Secondary breast cancer being incurable does not, on its own, meet that test. Someone can live with a secondary diagnosis, responding well to treatment, for considerably longer than twelve months, in which case a terminal illness claim made at diagnosis is likely to be declined, not because the insurer doubts the seriousness of the illness, but because the specific prognosis test in the policy wording is not yet satisfied.

This gap between the clinical reality and the insurance definition is the single most common source of confusion and distress for people navigating a secondary breast cancer diagnosis and a life policy at the same time, and understanding it clearly from the outset avoids a painful surprise later. How family history and diagnosis are defined differently again for underwriting purposes shows a related example of how insurance definitions can diverge from everyday clinical language, if it is useful to see the pattern repeated elsewhere.

What survival with secondary breast cancer actually looks like

Survival with secondary breast cancer varies enormously between individuals, depending on factors including where the cancer has spread to, the specific type of breast cancer involved, and how well it responds to the various available treatments, which for hormone-receptor-positive and HER2-positive disease in particular have improved substantially in recent years. National cancer registration data collected in England shows that a meaningful proportion of people diagnosed with secondary breast cancer survive for several years following diagnosis, reflecting genuine, measurable progress in treatment over the period covered by the most recent published statistics.

Source: NHS England / National Disease Registration Service, Cancer Survival in England, cancers diagnosed 2018 to 2022.

This is precisely why the twelve-month insurance test and the underlying clinical reality can sit years apart for many people. A diagnosis that is genuinely terminal, in that it cannot be cured and will most likely eventually be fatal, is not automatically a diagnosis with a twelve-month prognosis, and the improving survival figures over recent years make this gap, if anything, wider than it once was for people responding well to modern treatment.

What should I do while I wait for a claim to become possible?

The most important practical step is to keep every relevant life insurance policy in force, paying premiums as normal, throughout this period. Some insurers will not reinstate a lapsed policy once the policyholder is known to be seriously unwell, or will only do so with fresh medical underwriting that a current diagnosis makes very difficult to pass, so a policy allowed to lapse during this waiting period can be lost altogether, at exactly the point it may later be needed most.

It is also worth checking the term of the policy against how the illness might realistically progress. A policy due to end in, say, three years is of limited use if a terminal illness claim only becomes possible in year four, so this is worth reviewing rather than assuming the cover will simply still be there when needed. What is involved in applying for new cover after cancer treatment covers the separate question of arranging fresh insurance following a cancer diagnosis, which is realistically much harder once secondary disease is involved, making it more important to protect what is already in place.

Beyond the policy itself, this is a sensible time to check that a will is up to date, that any life policies are written in trust so that a future claim, when it becomes possible, is paid quickly rather than waiting for probate, and that pension nominations reflect current wishes. How a policy held in trust affects a future claim and inheritance tax is worth reading now, while there is time to act calmly, rather than only once a claim is imminent.

Will treatment changes affect a future claim?

Insurers' medical officers look at the whole clinical picture when assessing whether a prognosis has moved inside the twelve-month window, not simply the original diagnosis. A number of developments commonly form part of that picture: a decision that active, disease-modifying treatment is no longer suitable or effective and that care is moving towards symptom control, exhausting the realistic further lines of systemic therapy available, noticeable and rapid clinical deterioration, or a referral to a specialist palliative care team for symptom management and support.

None of these on their own guarantees that a claim will succeed, since the final judgement is a clinical one made by a doctor, usually the treating oncologist or palliative care consultant, applying their own professional opinion about likely life expectancy. But recognising these as the kind of milestones an insurer's medical officer will look for helps in understanding when it may be worth asking your consultant directly whether they would now be able to support a terminal illness claim, rather than waiting indefinitely without raising the question. How to claim terminal illness benefit in the UK sets out the practical claims process itself for when that point is reached.

Support beyond the insurance question

Living with a secondary breast cancer diagnosis, and managing an insurance policy at the same time, is a great deal to carry alone. Macmillan Cancer Support and Breast Cancer Now both offer specialist information and support specifically for people living with secondary breast cancer, including practical and financial guidance that goes well beyond the insurance question covered here, and speaking to a Macmillan nurse or one of their benefits advisers can help make sense of the wider financial picture alongside any insurance claim.

Source: Macmillan Cancer Support, living with secondary breast cancer, macmillan.org.uk.

The financial planning that sits alongside the insurance question

While the twelve-month test is being worked through, it is worth remembering that a terminal illness claim is only one part of the household's financial position, and often not the first source of money that becomes available. Statutory sick pay, and later Employment and Support Allowance or Universal Credit depending on circumstances, may be available well before any insurance claim is possible, and it is worth checking entitlement early rather than assuming nothing is available until an insurance claim succeeds. Many employers also offer a death-in-service benefit that is entirely separate from any personal life policy, and it is worth confirming with an employer's HR team exactly what that scheme offers and under what circumstances it would pay.

If a mortgage is part of the household's finances, it is also worth checking whether a decreasing or level term policy was arranged specifically to cover it, and whether that policy includes terminal illness benefit on the same twelve-month basis described here. A policy that would eventually clear the mortgage on a death claim, but cannot yet pay a terminal illness benefit because the twelve-month test is not met, still needs its premiums maintained in exactly the same way, since the mortgage debt itself does not pause while the prognosis develops.

Talking to your consultant about the prognosis question directly

It can feel uncomfortable to raise the specific question of life expectancy with a treating oncologist, particularly when the relationship has, up to that point, been focused entirely on managing the disease and discussing treatment options rather than end-of-life timescales. It is nonetheless a reasonable and common question for patients and families in this situation to ask, and consultants who specialise in secondary breast cancer are generally used to discussing prognosis openly when a patient specifically wants that conversation, even if they would not necessarily raise it unprompted.

A useful way to frame the question is not simply "how long do I have", which can be difficult for any clinician to answer precisely, but specifically whether, in the consultant's clinical opinion, life expectancy is now likely to be twelve months or less, since that is the exact wording most insurers need addressed. Bringing a copy of the policy's terminal illness definition to the appointment, or asking the insurer in advance exactly what wording they need a report to contain, can help the consultant provide a report that actually answers the question the insurer is asking, rather than a general clinical summary that leaves the position unclear.

Scotland and Northern Ireland

The definition of terminal illness benefit and the twelve-month prognosis test used by UK insurers apply in the same way regardless of where in the UK you live, since insurance products are typically sold across the whole of Great Britain and Northern Ireland on the same policy wording. What can differ locally is the wider administration of an estate should a claim eventually lead to a death, since Scotland uses confirmation rather than probate and has its own succession rules, while Northern Ireland has its own probate procedure and intestacy figures, both of which sit entirely separately from the insurance claim itself and only become relevant afterwards.

Frequently asked questions

Is secondary breast cancer classed as terminal?

Clinically it is treatable but not curable, and many people live with it for years. Insurers do not use that definition: a terminal illness claim needs a doctor to expect death within twelve months, which usually comes much later in the course of the illness.

What should I do while I wait?

Keep every policy in force, because a lapsed premium cannot always be reinstated once you are unwell. Check whether the term ends before your prognosis is likely to shorten, confirm whether policies are in trust, and make sure pension nominations and the will say what you want now.

Will treatment changes affect a future claim?

They can. Moving from active treatment to symptom control, a decision that no further lines of therapy are suitable, or a referral to a palliative care team, all form part of the picture an insurer's medical officer considers when assessing prognosis.